Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Epidemiology of Chemotherapy-Induced Anemia in Patients with Non-Hodgkin Lymphoma.

Cannavale K, Xu H, Xu L, Sattayapiwat O, Rodriguez R, Bohac C, Page J, Chao C.

Perm J. 2019;23. doi: 10.7812/TPP/18-252. Epub 2019 Jun 27.

2.

First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1.

Somaiah N, Block MS, Kim JW, Shapiro GI, Do KT, Hwu P, Eder JP, Jones RL, Lu H, Ter Meulen JH, Bohac C, Chen M, Hsu FJ, Gnjatic S, Pollack SM.

Clin Cancer Res. 2019 Jun 21. doi: 10.1158/1078-0432.CCR-19-1025. [Epub ahead of print]

PMID:
31227504
3.

Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review.

Riedel RF, Jones RL, Italiano A, Bohac C, Thompson JC, Mueller K, Khan Z, Pollack SM, Van Tine BA.

Cancers (Basel). 2018 Nov 1;10(11). pii: E417. doi: 10.3390/cancers10110417. Review.

4.

Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review.

Lacouture ME, Anadkat M, Jatoi A, Garawin T, Bohac C, Mitchell E.

Clin Colorectal Cancer. 2018 Jun;17(2):85-96. doi: 10.1016/j.clcc.2017.12.004. Epub 2017 Dec 13.

5.

Transfusion practice patterns in patients with anemia receiving myelosuppressive chemotherapy for nonmyeloid cancer: results from a prospective observational study.

Granfortuna J, Shoffner K, DePasquale SE, Badre S, Bohac C, De Oliveira Brandao C.

Support Care Cancer. 2018 Jun;26(6):2031-2038. doi: 10.1007/s00520-017-4035-7. Epub 2018 Jan 19.

6.

Efficacy and safety of darbepoetin alfa initiated at hemoglobin ≤10 g/dL in patients with stage IV cancer and chemotherapy-induced anemia.

Boccia RV, Henry DH, Belton L, Bohac C, Ghazal HH.

Cancer Med. 2016 Dec;5(12):3445-3453. doi: 10.1002/cam4.958. Epub 2016 Nov 23.

7.

Patient and health care provider perceptions of cancer-related fatigue and pain.

Williams LA, Bohac C, Hunter S, Cella D.

Support Care Cancer. 2016 Oct;24(10):4357-63. doi: 10.1007/s00520-016-3275-2. Epub 2016 May 20.

8.

The effect of chemotherapy-induced anemia on dose reduction and dose delay.

Family L, Xu L, Xu H, Cannavale K, Sattayapiwat O, Page JH, Bohac C, Chao C.

Support Care Cancer. 2016 Oct;24(10):4263-71. doi: 10.1007/s00520-016-3258-3. Epub 2016 May 11.

PMID:
27167627
9.

Hemoglobin levels and quality of life in patients with symptomatic chemotherapy-induced anemia: the eAQUA study.

Mouysset JL, Freier B, van den Bosch J, Levaché CB, Bols A, Tessen HW, Belton L, Bohac GC, Terwey JH, Tonini G.

Cancer Manag Res. 2016 Jan 21;8:1-10. doi: 10.2147/CMAR.S88110. eCollection 2016.

10.

Effects of erythropoiesis-stimulating agents on survival and other outcomes in patients with lymphoproliferative malignancies: a study-level meta-analysis.

Hedenus M, Osterborg A, Tomita D, Bohac C, Coiffier B.

Leuk Lymphoma. 2012 Nov;53(11):2151-8. doi: 10.3109/10428194.2012.684347. Epub 2012 May 22.

Supplemental Content

Loading ...
Support Center